465 related articles for article (PubMed ID: 20603197)
1. Comparative pharmacokinetics and bioavailability studies of quercetin, kaempferol and isorhamnetin after oral administration of Ginkgo biloba extracts, Ginkgo biloba extract phospholipid complexes and Ginkgo biloba extract solid dispersions in rats.
Chen ZP; Sun J; Chen HX; Xiao YY; Liu D; Chen J; Cai H; Cai BC
Fitoterapia; 2010 Dec; 81(8):1045-52. PubMed ID: 20603197
[TBL] [Abstract][Full Text] [Related]
2. Enhanced dissolution rate and oral bioavailability of Ginkgo biloba extract by preparing solid dispersion via hot-melt extrusion.
Wang W; Kang Q; Liu N; Zhang Q; Zhang Y; Li H; Zhao B; Chen Y; Lan Y; Ma Q; Wu Q
Fitoterapia; 2015 Apr; 102():189-97. PubMed ID: 25446043
[TBL] [Abstract][Full Text] [Related]
3. Proliposomes containing a bile salt for oral delivery of Ginkgo biloba extract: Formulation optimization, characterization, oral bioavailability and tissue distribution in rats.
Zheng B; Teng L; Xing G; Bi Y; Yang S; Hao F; Yan G; Wang X; Lee RJ; Teng L; Xie J
Eur J Pharm Sci; 2015 Sep; 77():254-64. PubMed ID: 26116277
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels and distribution of flavonoids in rat brain after single and repeated doses of standardized Ginkgo biloba extract EGb 761®.
Rangel-Ordóñez L; Nöldner M; Schubert-Zsilavecz M; Wurglics M
Planta Med; 2010 Oct; 76(15):1683-90. PubMed ID: 20486074
[TBL] [Abstract][Full Text] [Related]
5. Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves.
Sloley BD; Urichuk LJ; Morley P; Durkin J; Shan JJ; Pang PK; Coutts RT
J Pharm Pharmacol; 2000 Apr; 52(4):451-9. PubMed ID: 10813558
[TBL] [Abstract][Full Text] [Related]
6. VERIFICATION OF AUTHENTICITY OF
Budeč M; Bošnir J; Racz A; Lasić D; Brkić D; Mosović Ćuić A; Kuharić Ž; Jurak G; Barušić L
Acta Clin Croat; 2019 Dec; 58(4):672-692. PubMed ID: 32595253
[No Abstract] [Full Text] [Related]
7. A phospholipid complex to improve the oral bioavailability of flavonoids.
Wang H; Cui Y; Fu Q; Deng B; Li G; Yang J; Wu T; Xie Y
Drug Dev Ind Pharm; 2015; 41(10):1693-703. PubMed ID: 25496311
[TBL] [Abstract][Full Text] [Related]
8. Systemic and cerebral exposure to and pharmacokinetics of flavonols and terpene lactones after dosing standardized Ginkgo biloba leaf extracts to rats via different routes of administration.
Chen F; Li L; Xu F; Sun Y; Du F; Ma X; Zhong C; Li X; Wang F; Zhang N; Li C
Br J Pharmacol; 2013 Sep; 170(2):440-57. PubMed ID: 23808355
[TBL] [Abstract][Full Text] [Related]
9. Interactions of pharmacokinetic profile of different parts from Ginkgo biloba extract in rats.
Guan H; Qian D; Ren H; Zhang W; Nie H; Shang E; Duan J
J Ethnopharmacol; 2014 Aug; 155(1):758-68. PubMed ID: 24953034
[TBL] [Abstract][Full Text] [Related]
10. Phytic acid enhances the oral absorption of isorhamnetin, quercetin, and kaempferol in total flavones of Hippophae rhamnoides L.
Xie Y; Luo H; Duan J; Hong C; Ma P; Li G; Zhang T; Wu T; Ji G
Fitoterapia; 2014 Mar; 93():216-25. PubMed ID: 24462958
[TBL] [Abstract][Full Text] [Related]
11. Disposition of quercetin and kaempferol in human following an oral administration of Ginkgo biloba extract tablets.
Wang FM; Yao TW; Zeng S
Eur J Drug Metab Pharmacokinet; 2003; 28(3):173-7. PubMed ID: 14527089
[TBL] [Abstract][Full Text] [Related]
12. Involvement of P-glycoprotein in regulating cellular levels of Ginkgo flavonols: quercetin, kaempferol, and isorhamnetin.
Wang Y; Cao J; Zeng S
J Pharm Pharmacol; 2005 Jun; 57(6):751-8. PubMed ID: 15969930
[TBL] [Abstract][Full Text] [Related]
13. High-performance liquid chromatographic determination of selected flavonols in Ginkgo biloba solid oral dosage forms.
Dubber MJ; Kanfer I
J Pharm Pharm Sci; 2004 Sep; 7(3):303-9. PubMed ID: 15576009
[TBL] [Abstract][Full Text] [Related]
14. Effects of solid dispersion and self-emulsifying formulations on the solubility, dissolution, permeability and pharmacokinetics of isorhamnetin, quercetin and kaempferol in total flavones of Hippophae rhamnoides L.
Zhao G; Duan J; Xie Y; Lin G; Luo H; Li G; Yuan X
Drug Dev Ind Pharm; 2013 Jul; 39(7):1037-45. PubMed ID: 22757776
[TBL] [Abstract][Full Text] [Related]
15. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1.
Chang TK; Chen J; Yeung EY
Toxicol Appl Pharmacol; 2006 May; 213(1):18-26. PubMed ID: 16226778
[TBL] [Abstract][Full Text] [Related]
16. Effect of Ginkgo biloba extract on rat hepatic microsomal CYP1A activity: role of ginkgolides, bilobalide, and flavonols.
Kuo If; Chen J; Chang TK
Can J Physiol Pharmacol; 2004 Jan; 82(1):57-64. PubMed ID: 15052306
[TBL] [Abstract][Full Text] [Related]
17. [Determination of 7 flavonol glycosides in Ginkgo biloba reference extract].
Wang JH; Chen J; Wang MM; Fu XT; Chen YG; Guo HZ
Zhongguo Zhong Yao Za Zhi; 2015 Oct; 40(20):4018-21. PubMed ID: 27062820
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic properties of isorhamnetin, kaempferol and quercetin after oral gavage of total flavones of Hippophae rhamnoides L. in rats using a UPLC-MS method.
Li G; Zeng X; Xie Y; Cai Z; Moore JC; Yuan X; Cheng Z; Ji G
Fitoterapia; 2012 Jan; 83(1):182-91. PubMed ID: 22056665
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic herb-disease-drug interactions: Effect of ginkgo biloba extract on the pharmacokinetics of pitavastatin, a substrate of Oatp1b2, in rats with non-alcoholic fatty liver disease.
Li Z; Tian S; Wu Z; Xu X; Lei L; Li Y; Wang B; Huang Y
J Ethnopharmacol; 2021 Nov; 280():114469. PubMed ID: 34329714
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human CYP2B6-catalyzed bupropion hydroxylation by Ginkgo biloba extract: effect of terpene trilactones and flavonols.
Lau AJ; Chang TK
Drug Metab Dispos; 2009 Sep; 37(9):1931-7. PubMed ID: 19487249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
